Keywords:
Laparoscopy - Leiomyosarcoma - Vena Cava - Inferior
Descritores:
Laparoscopia - Leiomiossarcoma - Veia cava inferior
INTRODUCTION
The inferior vena cava sarcoma (IVC) represents 2% of all leiomyosarcomas. It is a
tumor of mesenchymal origin of poor prognosis, because approximately 50% of patients
submitted to curative surgical resection will present recurrence of the disease. Leiomyosarcoma
represents 60% of IVC primary malignancy cases of the inferior vena cava, and until
the year 2010 there were less than 300 cases reported in medical literature on this
pathology. The diagnosis is more common in sexagenarian women and the segment of the
inferior vena cava most affected is located between the hepatic veins and the renal
veins.[
[1]
[2]
]
Surgical R0 resection in monoblock is the only form of curative treatment. The objectives
of surgery are complete resection of malignant neoplasia, prevention of locoregional
recurrence and venous return preservation. Due to the proximity to abdominal and retroperitoneal
structures, enlarged resections may be necessary to obtain free margins. Surgical
reconstruction of the vena cava is a controversial subject in the medical literature.
Adjuvant treatment with radiotherapy is not related to increased survival in patients
with leiomyosarcoma of the inferior vena cava; however, radiotherapy may assist in
local disease control.[
[2]
[3]
]
We report the case of a 73-year-old female patient with IVC leiomyosarcoma who underwent
surgical R0 resection by videolaparoscopy. Reconstruction of the vena cava was not
performed due to her low blood flow in the preoperative period and to the good development
of collateral vascular systems. No neoadjuvant or adjuvant treatment has been performed.
CASE REPORT
R.M.B, 73-years-old, female, presenting abdominal discomfort, started in August 2015,
with chronic and progressive evolution without irradiation and without other associated
symptoms. The patient underwent these propaedeutic exams in March of 2016. Magnetic
resonance image (MRI) upper abdomen floor showing expansive lesion with lush and heterogeneous
enhancement after intravenous contrast located up retroperitoneal previously shifting
the head of the pancreas and caudal duodenal arc, and keeping in touch with the right
wall of the aorta, without definite signs of invasion of these structures and without
a cleavage plane with the inferior vena cava, and may represent its primary lesion
([Figure 1]). Biopsy performed during echoendoscopy revealed histological and immunohistochemical
findings compatible with leiomyosarcoma. Tests performed for staging did not demonstrate
signs of distant metastasis.
Figure 1 Para-aortic retroperitoneal lesion in the inferior vena cava topography with heterogeneous
impregnation by contrast and restricted diffusibility.
Patient submitted to videolaparoscopic surgery in April 2016 for leiomyosarcoma treatment
of the inferior vena cava located below renal veins and above the iliac vein bifurcation
(segment I). Six trocars were arranged as follows: umbilical of 10mm, in the right
flank of 12mm, in the left iliac fossa of 12mm, in the left flank of 5mm, in the right
iliac fossa of 5mm and in epigastric region 5mm port. Dissection ([Figure 2]) and R0 resection of neoplasia and ligature of inferior vena cava with vascular
(beige) Endogia® were performed. As in the preoperative examinations, the flow in the inferior vena
cava was very low; it was chosen not to use graft or vascular prosthesis, due to the
presence of well-developed collateral vascularization. Removal of the surgical piece
([Figure 3]) in a monoblock was through umbilical portal, Endogia® coated to protect the abdominal wall.
Figure 2 Dissection: distal and posterior repair of the inferior vena cava.
Figure 3 Intraluminal tumour and negative margin.
The surgery time was approximately 2h40min, and there was no intraoperative complication.
An oral diet was introduced on the first postoperative day and the patient was discharged
on the third postoperative day. Prophylactic heparinization was performed with enoxiparin
1mg/kg once daily for 30 days postoperatively.
Histological and immunohistochemical profile positive for desmin and smooth muscle
actin. The diagnosis consistent with grade 1 leiomyosarcoma of 4 centimeters arising
from the IVC with endophytic extension. Macro and microscopic negative margins.
After 30 months of follow up, the patient is asymptomatic, with no lower extremity
lymphedema or thrombosis and no locoregional disease. She presented liver and lung
metastasis, and is currently receiving combined chemotherapy with doxorubicin and
olaratumab.
DISCUSSION
Primary leiomyosarcoma of inferior vena cava is a rare neoplasm and of poor prognosis,
which develops from the smooth muscle constituents of the media layer of the blood
vessel. It is the most common tumor of the venous system where the inferior vena cava
and the most affected vessel. IVC leiomyosarcoma presents classification defined by
its location: segment I (lower), below the renal vessels (IVC infrarenal); Segment
II (middle): between the origin of renal vessels and the hepatic vein; Segment III
(superior): between the origin of the hepatic veins to the right atrium (IVC suprahepatic).
The majority of tumors are located in the middle segment (50.8%) and lower segment
(44.2%). In our study, the patient presented IVC leiomyosarcoma in segment I.[
[2]
[3]
[4]
[5]
[6]
[7]
[8]
]
In patients with metastasis and in those cases where it will not be possible to perform
R0 resection, it must performed neoadjuvant treatment and evaluate the possibility
of R0 resection later. For patients submitted to surgical resection the next step
is to analyze the margins of the surgical part. In case of free margins, the patient
will be monitored and in case of positive margins, should be performed adjuvant treatment.[
[3]
[7]
[8]
]
Chemotherapy and radiotherapy are not associated with increased patient survival;
however, radiotherapy seems to help in local disease control. Reconstruction of the
vena cava after resection of the tumor is a very controversial subject since some
authors believe that this procedure would increase intraoperative time by increasing
the morbidity of the procedure. In addition they believe that the patient is able
to tolerate well the ligature of the inferior vena cava.[
[3]
[4]
[6]
[7]
[8]
] Other authors argue in favor of the vena cava reconstruction for all patients, since
the ligation of the vena cava will compromise venous return and cause lower extremity
edema in patients. Reconstruction of the IVC can be done by autologous grafts, prostheses
and vascular derivations.[
[4]
[5]
[7]
[8]
]
After a careful literary survey on this subject (BIREME, Portal CAPES, PubMed and
RIMA), we did not find studies that report videolaparoscopy as an access way in surgical
resection of this type of tumor. All reports mention the laparotomy.
Just only one paper report a laparoscopic excision of an exophytic tumour without
any intraluminal extension and no compromising IVC lumen.[
[9]
] About these case we agree with others authors, partial resection of the IVC may lead
to increased risk of tumor recurrence and an inadequate resection margin. It has been
suggested that patients with leiomyosarcoma of the IVC should undergo complete resection
of the portion of the IVC where the tumor is present.[
[10]
]
In our report, the patient underwent total laparoscopic monoblock resection of the
inferior vena cava and leiomyosarcoma with free margins, and the surgical time was
similar to that of the laparotomy procedure described by other authors. The patient
was given oral diet on the first postoperative day and hospital discharge on the third
postoperative day, that is, there was a significant reduction in the length of hospital
stay, contributing to a reduction in morbidity.
Bibliographical Record
Roberto Heleno Lopes, Antônio Carlos Rodrigues do Nascimento, Alexandre Ferreira Oliveira,
Frederico Augustus Martins de Resende, João Baptista de Paula Fraga, Isolino Geraldo
Almeida. Complete laparoscopic resection of primary leiomyosarcoma of the lower vena
cava. Brazilian Journal of Oncology 2020; 16: e-20200022.
DOI: 10.5935/2526-8732.20200022
